Chronic Kidney Disease as a Comorbidity in Heart Failure

Chronic Kidney Disease as a Comorbidity in Heart Failure

Heart failure (HF) is one of the greatest problems in healthcare and it often coexists with declining renal function. The pathophysiology between the heart and the kidneys is bidirectional. Common mechanisms leading to the dysfunction of these organs result in a vicious cycle of cardiorenal deterior...

Full description

Bibliographic Details
Main Authors:	Magdalena Szlagor, Jill Dybiec, Ewelina Młynarska, Jacek Rysz, Beata Franczyk
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	International Journal of Molecular Sciences
Subjects:	heart failure (HF) chronic kidney disease (CKD) GFR ejection fraction renin–angiotensin–aldosterone system inhibitors (RAAS-I) mineralocorticoid receptor antagonists (MRAs)
Online Access:	https://www.mdpi.com/1422-0067/24/3/2988

Similar Items

Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease
by: Wiktoria Baran, et al.
Published: (2021-09-01)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
by: Marisa K. Ames, et al.
Published: (2022-11-01)

Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
by: Anastasia V. Poznyak, et al.
Published: (2021-06-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

Serum potassium level and mineralocorticoid receptor antagonist dose in a large cohort of chronic heart failure patients
by: Pascal R. D. Clephas, et al.
Published: (2023-04-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
by: Jilong XU, et al.
Published: (2023-02-01)

Hyperkalemia in heart failure patients: current challenges and future prospects
by: López-Vilella R, et al.
Published: (2016-02-01)

Renin–Angiotensin–Aldosterone System: From History to Practice of a Secular Topic
by: Sara H. Ksiazek, et al.
Published: (2024-04-01)

Factors Associated With Maintenance of an Improved Ejection Fraction: An Echocardiogram‐Based Registry Study
by: Brenna McElderry, et al.
Published: (2023-11-01)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
by: Yuta Tezuka, et al.
Published: (2021-03-01)

Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia
by: Shun Kohsaka, et al.
Published: (2022-09-01)

Antihypertensive effects of pentacyclic triterpenoid from Convolvulus pluricaulis and its plausible mechanism of action hypothesizing its selectivity targeting Mineralocorticoid receptor of RAAS.
by: Kanagasabai Somarathinam, et al.
Published: (2023-02-01)

Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
by: Ki Hong Choi, et al.
Published: (2018-11-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01)

Pathomechanisms of Diabetic Kidney Disease
by: Satyesh K. Sinha, et al.
Published: (2023-11-01)

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
by: Jinbo Hu, et al.
Published: (2021-12-01)

Bone morphogenetic protein 4 in perivascular adipose tissue ameliorates hypertension through regulation of angiotensinogen
by: Wen-Juan Mu, et al.
Published: (2022-11-01)

Effects of Interactions among Gene Polymorphisms of the Renin–Angiotensin-Aldosterone System on Hypertension in Turkish People from Southeast Anatolia
by: Arpacı Abdullah, et al.
Published: (2019-04-01)

Renin Feedback Is an Independent Predictor of Outcome in HFpEF
by: Christina Binder, et al.
Published: (2021-05-01)

RAA System and Exercise Relationship
by: Sadettin Ünsal, et al.
Published: (2019-09-01)

Structural and Functional Changes in Aging Kidneys
by: Jill Dybiec, et al.
Published: (2022-12-01)

Heart failure: the role for mineralocorticoid receptor antagonists
by: Bertram Pitt
Published: (2014-05-01)

Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
by: Dejan Marčetić, et al.
Published: (2021-07-01)

Association of Elevated Serum Aldosterone Concentrations in Pregnancy with Hypertension
by: Robin Shoemaker, et al.
Published: (2023-11-01)

Bidirectional relationship between covid-19 and diabetes: Role of renin–angiotensin–aldosterone system and drugs modulating it
by: Razia Khanam
Published: (2021-01-01)

Endoplasmic Reticulum (ER) Stress in Part Mediates Effects of Angiotensin II in Pancreatic Beta Cells
by: Ramalingam L, et al.
Published: (2020-08-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences
by: Minela Aida Maranduca, et al.
Published: (2022-09-01)

Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy
by: Haru Nomura, et al.
Published: (2022-01-01)

The new Era of non-Steroidal Mineralocorticoid Antagonists in Treating Heart Failure in Diabetic Kidney Disease Patients.
by: Eqerem Hasani, et al.
Published: (2022-01-01)

The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients
by: Marco Vicenzi, et al.
Published: (2020-09-01)

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
by: Xinwu Huang, et al.
Published: (2017-06-01)

Low plasma renin activity is associated with “Apparently” idiopathic atrial fibrillation
by: Youmei Shen, et al.
Published: (2023-12-01)

Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin–angiotensin–aldosterone system on COVID-19 disease
by: Christian M. Zobel, et al.
Published: (2024-01-01)

Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
by: Nestor Vazquez-Agra, et al.
Published: (2023-03-01)

PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
by: O. M. Drapkina, et al.
Published: (2017-09-01)